ELOVL5 and breast carcinoma: Furthermore, we clearly confirmed that ablation of Elovl5 expression with siRNA or shRNA in breast cancer cells inhibited cell proliferation (Supplementary Fig. S7A–C) and promoted cell invasion (Fig. 7C, D and Supplementary Fig. S7D).